Corcept Therapeutics Inc. (NASDAQ:CORT) shares shot up 1.8% on Monday . The company traded as high as $5.66 and last traded at $5.63, with a volume of 72,288 shares. The stock had previously closed at $5.53.

A number of research firms recently weighed in on CORT. FBR & Co reaffirmed a “buy” rating on shares of Corcept Therapeutics in a research note on Thursday, August 4th. Zacks Investment Research downgraded Corcept Therapeutics from a “buy” rating to a “hold” rating in a research note on Thursday, July 28th.

The company has a market capitalization of $638.13 million and a PE ratio of 641.11. The company has a 50 day moving average of $5.80 and a 200 day moving average of $5.04.

Corcept Therapeutics (NASDAQ:CORT) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. The firm earned $19.70 million during the quarter, compared to analysts’ expectations of $18.36 million. On average, analysts predict that Corcept Therapeutics Inc. will post $0.05 EPS for the current year.

Corcept Therapeutics Inc is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company’s focus is on those disorders that are associated with a steroid hormone cortisol. Elevated levels and abnormal release patterns of cortisol have been implicated in a range of human disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.